Blood Cancer Awareness

Cancer is one of the biggest enemies of humanity. It’s important to reflect on how far we’ve come. My expertise is in treating blood cancer, so I’d like to share some thoughts.

It is the most exciting time in the history of blood cancer research.

In the past two decades, many new drugs have been approved, including targeted therapies that have revolutionized the treatment and survival of blood tumors.

Over the last two decades, blood cancer management has also improved in our country. Hematopoietic Stem Cell Transplant, one of the mainstays of management for blood cancer and certain solid cancers, is now more accessible and safer than it was ten years ago.

Hematopoietic Stem Cell Transplant, or Bone Marrow Transplant, is a non-surgical procedure that can be autologous or allogeneic.

  • Autologous Stem Cell Transplant is a procedure that involves the collection of stem cells by self over a 4-6 hour period, followed by high-dose chemotherapy. The stem cells are then re-infused. This type of stem cell transplant is often used for conditions such as Multiple myeloma and Relapsed Lymphomas.
  • The allogeneic stem-cell transplant involves the collection of stem cells from an anonymous donor, followed by high-dose chemotherapy and infusion. The stem cell donor can come from either the family registry or an international registry of donors based on the HLA match. The HLA matching process for stem cell transplants is similar to the blood group matching procedure for blood transfusion. This is done in cases such as leukemias, myelodysplastic Syndrome, and non-cancerous diseases like thalassemias or aplastic anemias. It can be performed for primary immunodeficiencies (PNH), sickle cells, etc.

Transplantation is often the only option for a patient. Patients with blood cancer who don’t see a way out can now access hematopoietic cell transplants, which offer hope. If complications are avoided, the patient has a good chance of being cured.

Max Super-Speciality Hospital feels honored and humbled that we can provide this life-saving treatment to patients from India and worldwide. We strive to improve our results to meet international standards. We work every day to combat the threat of blood cancer and think about ways to make it safer and better for our patients.

Even though world-class healthcare is readily available, poor accessibility remains a significant problem in our country. We are working with government and nongovernmental organizations to improve the accessibility of Hematopoietic Stem Cell Transplants for every needy patient.